Global Voice Prosthesis Devices and Equipment Market Report 2021: COVID-19 Impact and Recovery to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Voice Prosthesis Devices and Equipment Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to ResearchAndMarkets.com’s offering.

The global voice prosthesis devices and equipment market is expected to grow from $0.45 billion in 2020 to $0.5 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $0.56 billion in 2025 at a CAGR of 2.9%.

Technological advancements of voice prosthesis devices and equipment have increased various properties of devices including, lifetime of the device, simple and easy maintenance by patients, and comfortable outpatient replacements. For instance, the Indwelling prostheses are designed to meet the criteria of low air resistance and optimal retention in the tracheoesophageal wall, these prostheses devices and equipment have become the valve of choice with the success rate of 40-90% having very good voice quality.

The voice prosthesis device and equipment market is driven by an increasing number of cases of larynx cancer. Larynx cancer is a disease in which malignant cancer cells form tissue in the larynx and cause sore throat and ear pain. According to the WHO, there were 99840 deaths reported in 2020 due to Larynx cancer.

High equipment cost of voice prosthesis devices and equipment hampers the voice prosthesis devices and equipment market growth. High equipment costs refer to the replacement of prosthesis devices and equipment after a certain period of time. For instance, JAMA Otolaryngol Head Neck Surgery center found that average life of the prosthesis devices and equipment is 3-6 months after which the device has to be changed.

Medical devices including ENT surgical devices enter the market through FDA 510(K) premarket clearance pathway, As announced by FDA in November 2018 this regulation is set to undergo changes in which more efficient medical devices clearance process to introduce a new generation of safety, technology, and capabilities in medical devices. The EU’s Medical Device Regulation (MDR) came into force in 2020. The future of ENT devices is likely to be impacted by both modernization of FDA 510(k) pathway and forthcoming enforcement of new EU MDR regulations.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

• The Market Characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:

1) By Device Type: Indwelling Voice Prosthesis Devices; Non-Indwelling Voice Prosthesis Devices

2) By Product Type: Soft Valve Assembly; Hard Valve Assembly; Others

3) By Valve Type: Blom-Singer valve; Provox valve; Groningen valve

4) By Material: Silicone Rubber; Silicone; Fluoroplastic; Silver Oxide; Others

5) By End User: Hospitals; Ambulatory Surgical Centers; Clinics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Companies Mentioned

• Atos Medical
• Andreas Fahl Medizintechnik-Vertrieb
• Servona
• Acclarent Inc. (A Subsidiary of Johnson & Johnson)
• Karl Storz Gmbh & Co. Kg
• Smith & Nephew PLC
• InHealth Technologies
• HEIMOMED Heinze
• Sonova Holding AG
• William Demant Holding A/S
• Smiths Medical

For more information about this report visit https://www.researchandmarkets.com/r/ipldax

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900